Phase 3 Study of PF-06801591 in Combination with Bacillus Calmette-Guerin (BCG) in Participants with High-Risk Non-Muscle Invasive Bladder Cancer

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/63230/ MonH-2020- 217188(v2)
NMA SSA Reference Number: SSA/63230/MonH-2020-220786(v1)
Monash Health Reference: RES-20-0000-262A
StatusActive
Effective start/end date23/07/2022/07/25

Keywords

  • clinical trial
  • phase 1 study
  • bladder cancer
  • treatment efficacy
  • treatment safety